Does human semen contain a functional haemostatic system? A possible role for Tissue Factor Pathway Inhibitor in fertility through semen liquefaction

Thrombosis and Haemostasis

Volumn 93, Issue 5, 2005, Pages 847-852

  Lwaleed, Bashir A ^a   Greenfield, Robert S ^b   Birch, Brian R ^a   Cooper, Alan J ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b American Diagnostica Inc   (United States)

Author keywords

Fertility; Human semen; Novel finding; Tissue Factor Pathway Inhibitor (TFPI)

Indexed keywords

THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BLOOD CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOSTASIS; HUMAN; LIQUEFACTION; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MALE GENITAL TRACT PARAMETERS; PRIORITY JOURNAL; SEMEN ANALYSIS; SEMINAL PLASMA; SPERM DONOR; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SUBFERTILITY; VASECTOMY; VISCOSITY;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERTILITY; HEMOSTASIS; HUMANS; INFERTILITY, MALE; LIPOPROTEINS; MALE; MIDDLE AGED; SEMEN; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; THROMBOPLASTIN; TIME FACTORS; VASECTOMY;

EID: 18844460454     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-09-0600     Document Type: Article

References (35)

1. Huggins C, Neal W. Coagulation and liquefaction of semen. Proteolytic enzymes and citrate in prostatic fluid. J Exp Med 1942; 76: 527-41.
2. Tauber PF, Zaneveld LJD, Propping D, et al. Components of human split ejaculates. II. Enzymes and proteinase inhibitors. J Reprod Fertil 1976; 46: 165-71.
3. Mandal A, Bhattacharyya AK. Grouping the ejaculates according to the degree of coagulation and the relationship to the levels of choline and cholinesterase. Int J Androl 1986; 9: 407-15.
4. Masaki J. Biochemistry of semen. In: Spermatology. Mohri H, Morisawa M, Hoshi M (Eds). Tokyo, University of Tokyo Press 1992; 121-37.
5. van Wersch JWJ, Ubachs JHM, Dalaere KPJ. Fibrinolysis and coagulation markers in seminal plasma before and after vasectomy. Fibrinolysis 1993; 7: 135-8.
6. España F, Gilabert J, Estellés A, et al. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res 1991; 64: 309-20.
7. Carson SD, De Jonge CJ. Activation of coagulation factor X in human semen. J Androl 1998; 19: 289-94.
8. Fareed J, Callas DD, Hoppensteadt D, et al. Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinolysis 1995; 6: 32-6.
9. Fernández JA, Heeb MJ, Radtke K-P, et al. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor. Biol Reprod 1997; 56: 757-63.
10. Brody I, Ronquist G, Gottfries A. Ultrastructural localisation of the prostasome-an organelle in human seminal plasma. Upsala J Med Sci 1983; 88: 63-80.
11. Nemerson Y, Bach R. Tissue factor revisited. Prog Hemost Thromb 1982; 6: 237-61.
12. Nemerson Y. Tissue Factor: Then and now. Thromb Haemost 1995; 74: 180-4.
13. Broze GJ. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992; 29: 159-69.
14. Broze GJ. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis 1995; 6: 7-13.
15. Skibinski G, Kelley RW, Harkiss D, et al. Immunosupression by human seminal plasma-extracellular organelles (prostasomes) modulate activity of phagocytic cells. Am J Rerod Immunol 1992; 28: 97-103.
16. Lwaleed BA, Greenfield R, Stewart A, et al. Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb Haemost 2004; 92: 752-66.
17. World Health Organization: WHO Laboratory Manual for the examination of human semen and semen-cervical mucus interaction. Cambridge, Cambridge University Press; 2000.
18. Polak B, Daunter B. seminal plasma biochemistry. IV. enzymes involved in the liquefaction of human seminal plasma. Int J Androl 1989; 12: 187-94.
19. Ronquist G, Nilsson BO. Prostasomes. Wennergren International Series. London, Portland Press; 2002.
20. Matsuda Y, Shimokawa K, Katayama M, et al. Blood coagulation factor X (FX) in human seminal plasma. Arch Androl 2002; 48: 295-300.
21. Park JY, Yoshimara Y, Nozawa S, et al. Fibrinogen-like substance and thrombin like enzyme in human seminal plasma: coagulation of human semen. Arch Androl 1997; 38: 29-36.
22. Yamamuro M, Wada H, Kumeda K, et al. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1998; 6: 491-7.
23. Moghissi KS, Wallach EE. Unexplained infertility. Fertil Steril 1983; 39: 5-21.
24. Rümke P. The origin of immunoglobulins in semen. Clin Exp Immunol 1974; 17: 287-97.
25. Mandal A, Bhattacharyya AK. Relationship between the coagulation-liquefaction property of human ejaculates and their volume, sperm count and motility Clin Reprod Fertil 1987; 5: 367-71.
26. Elzanaty S, Richthoff J, Malm J, et al. The impact of epididymal and accessory sex gland function on sperm motility. Hum Reprod 2002; 17: 2904-11.
27. Zhao Y, Vlahos N, Wyncott D, et al. Impact of semen characteristics on the success of intrauterine insemination. J Assist Reprod Genet 2004; 21: 143-8.
28. Mahony MC, Alexander NJ. Sites of antisperm antibody action. Human Reprod 1991; 6: 1426-30.
29. D'Cruz OJ, Haas GG Jr, Wang B, et al. Activation of human complement by IgG antisperm antibody and the demonstration of C3 and C5b-9-mediated immune injury to human sperm. J Immunol 1991; 146: 611-20.
30. Ronquist G, Nilsson BO, Hjerten S. Interaction between prostasomes and spermatozoa from human semen. Arch Androl 1990; 24: 147-57.
31. Dong L, Peng Y, Wang R. Expression and its clinical significance of tissue factor pathway inhibitor and antithrombin-III in patients with hepatic inflammatory diseases. Chung Hua Kan Tsang Ping Tsa Chih 1999; 7: 224-5.
32. Koudsi B, Chatman DM, Ballinger BA, et al. Tissue factor pathway inhibitor protects the ischemic spinal cord. J Surg Res 1996; 63: 174-8.
33. Chen D, Riesbeck K, McVey JH, et al. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 2001; 8: 258-65.
34. Nakamura Y, Nakamura K, Ohta K, et al. Anti-inflammatory effects of long-lasting locally-delivered human recombinant tissue factor pathway inhibitor after balloon angioplasty. Basic Res Cardiol 2002; 97: 198-205.
35. Creasey AA, Chang AC, Feigen L, et al. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest 1993; 91: 2850-6.